Turmeric supplements: Do they really help with joint discomfort?
- 9 Dec 2024
- Shubhangi Madan
In our fast-paced world, joint discomfort can creep in unnoticed, often triggered by age, lifestyle factors, or simply the wear and tear of everyday movements. What might start as a mild, occasional twinge can slowly evolve into a constant ache that impacts our quality of life?
For many, the onset of joint discomfort is unexpected and disheartening, particularly when it disrupts activities once taken for granted. But what if the solution to this persistent ache lies in the vibrant golden hue of an ancient remedy?
Turmeric supplements, a game changer in joint health
Marketed as a golden powerhouse, this spice has transcended its place to become a staple in the health and wellness sphere. Turmeric has been more than just a colour boost to curry—it’s a time-tested medicinal herb that has been used in Ayurvedic and traditional Chinese medicine for centuries, with the key being Curcumin.
Role of turmeric supplements and their bioavailability
Joint pain often stems from inflammation—a response by the body to injury or chronic conditions like arthritis. Studies have shown that Curcumin (from turmeric) works by targeting this inflammation at the cellular level, reducing the pain, stiffness, and swelling associated with it. This makes turmeric supplements a ready pick for joint pain and other discomfort associated with joints.
However, choosing a turmeric supplement can be crucial, for curcumin has a very solubility and therefore bioavailability. This means not all supplements may impart an equal or promised health benefit.
Maxicuma exhibits superior bioavailability when compared to a conventional turmeric extract standardized to 95%, delivering 172 Folds More Free Curcumin in human blood plasma.
The extraordinary ingredient has been found to significantly reduce the symptoms of joint discomfort with a randomized, double-blind, placebo-controlled study that included 180 subjects of either sex aged between 45 and 65, with mild to moderate Osteoarthritis.
Maxicuma®: Proven to reduce joint discomfort
The participants were accessed at periodic intervals, on Day 0, 30, 45, 60, and 90 respectively, for Joint pain, Joint functions, and physical activity using validated scales like Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) and Visual Analog Scale (VAS), along with the objective assessment of physical performance by treadmill walk test.
The participants from both the active groups reported a statistically significant reduction in joint pain and improvement in other efficacy variables like joint stiffness, mobility, etc., from day 30 onwards against the placebo group. Within the active groups, Maxicuma® 250mg showed a statistically significant difference from Maxicuma® 100mg from day 45 onwards until the study’s completion.
